DBV Technologies (DBVT) Exchange Rate Effect (2020 - 2026)
DBV Technologies (DBVT) posted Exchange Rate Effect of -$1.1 million for Q2 2026, up 75.56% sequentially from -$4.5 million in Q1 2026, and down 115.28% YoY from $7.2 million in Q2 2025.
DBV Technologies (DBVT) Exchange Rate Effect (2020 - 2026) Analysis & Trends
DBV Technologies has reported Exchange Rate Effect for 7 years, with the latest figure at -$1.1 million in Q2 2026.
- Quarterly Exchange Rate Effect fell 115.28% year-over-year to -$1.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$5.2 million (down 171.65% YoY) and the FY2025 annual result came in at $8.1 million, up 289.32% from the prior year.
- Exchange Rate Effect improved to -$1.1 million in Q2 2026 per DBVT's latest filing, from -$4.5 million in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $20.7 million in Q4 2022 and troughed at -$14.6 million in Q3 2022.
- A 5-year average of -$132333.3 and a median of -$837500.0 in 2024 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2022 and 2026: Exchange Rate Effect jumped 1132.12% in 2022, then slumped 1000.0% in 2026.
- Over 5 years, Exchange Rate Effect stood at $20.7 million in 2022, then tumbled by 69.63% to $6.3 million in 2023, then tumbled by 150.89% to -$3.2 million in 2024, then jumped by 136.18% to $1.2 million in 2025, then slumped by 194.91% to -$1.1 million in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$1.1 million, -$4.5 million, and $1.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | DBV Technologies | 6.08 Bn | 5.90 Bn | - | -1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.10 Mn |
| Jun 30, 2026 | -1.10 Mn |
| Mar 31, 2026 | -4.50 Mn |
| Mar 31, 2026 | -4.50 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | -779,000.00 |
| Sep 30, 2025 | -779,000.00 |
| Jun 30, 2025 | 7.20 Mn |
| Jun 30, 2025 | 7.20 Mn |
| Mar 31, 2025 | 500,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | -3.20 Mn |
| Dec 31, 2024 | -3.20 Mn |
| Sep 30, 2024 | 2.79 Mn |
| Sep 30, 2024 | 2.79 Mn |
| Jun 30, 2024 | -896,000.00 |
| Jun 30, 2024 | -896,000.00 |
| Mar 31, 2024 | -2.96 Mn |
| Mar 31, 2024 | -2.96 Mn |